Tag: iShares Biotechnology ETF

Stocks making the biggest moves midday: Palantir, Flutter, United Airlines, Synopsys, Insmed & more

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Vertex passes key test in quest to treat kidney diseases

FDA vaccine head will step down in April after string of controversial decisions

FDA reversals leave investors worrying about the fates of other experimental drugs

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease

Three decades into cystic fibrosis fight, Boomer Esiason and his son Gunnar are winning

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal